Navigation Links
ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
Date:6/3/2008

Compound Emerged from Technology Licensed from Schering-Plough Research

Institute

ROCKVILLE, Md., June 3 /PRNewswire-FirstCall/ -- ViroDefense Inc today announced that it has chosen to advance a compound licensed to ViroDefense Inc by Schering-Plough Corporation into IND-enabling preclinical studies for the prevention and treatment of poliovirus infections.

Schering-Plough licensed to ViroDefense Inc the exclusive rights for development of a specific compound series for polio indications. The license was provided in exchange for the purchase of compound testing supplies and potential future royalties on sales. Schering-Plough Research Institute had been developing the series for treatment of diseases caused by non-polio enteroviruses, such as the coxsackie viruses. ViroDefense Inc determined in laboratory tests that compounds of the series had promising anti-poliovirus activity.

The licensed compounds belong to the antiviral mechanistic class termed "capsid inhibitors." Compounds of this class inhibit the function of the poliovirus capsid, the outer protein coat of the virus, by integrating into the capsid at a specific site or pocket. By doing so, they prevent virus "uncoating" and the release of the viral RNA from the capsid, thereby blocking the initiation of the viral infection cycle.

The lead anti-poliovirus compound, V-073, has been shown to have potent and broad-spectrum anti-poliovirus specific activity, favorable pharmacologic and pharmacokinetic attributes, and the safety and tolerability profile suitable for its advancement as a preclinical candidate. Consequently, IND- enabling studies will commence with V-073.

"We are grateful to Schering-Plough for their willingness to offer this promising antiviral series for the fight against polio," commented Marc S. Collett, President of ViroDefense Inc. "This is clearly a humanitarian gesture on their part."

"We are very pleased to s
'/>"/>

SOURCE ViroDefense Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
2. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
3. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
4. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
5. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
6. Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
7. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting
8. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
9. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
10. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
11. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015  Syneron Medical Ltd. (NASDAQ: ELOS ), a ... the three month period ended June 30, 2015. ... Highlights: , Revenue of $73.5 million, ... North American product sales grew 45% year-over-year. , International ... 14% product growth in the EMEA region and 25% product ...
(Date:8/4/2015)... , Aug. 4, 2015  Ironshore Pharmaceuticals ... with Restore Health, a company specializing in personalized ... double-blind clinical trial, designed to evaluate the safety ... development to treat Attention-deficit/hyperactivity disorder (ADHD). This is ... Restore Health originally partnered with Ironshore in ...
(Date:8/3/2015)... Aug. 4, 2015   The Intellectual Property ... world,s leading provider of intelligent information for businesses ... 2015 CMR Pharmaceutical R&D Factbook , the biopharmaceutical ... concerns around declines in R&D, the analysis identifies ... trillion milestone and forecasts sales to reach $1.3 ...
Breaking Medicine Technology:Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2Pharma Sales to Grow Beyond $1 Trillion 2
... March 31, 2011 Reportlinker.com announces that a new ... Cardiac Marker Diagnostic Testing Markets ... purpose of this TriMark Publications report is to describe ... (IVD) market devoted to cardiac marker testing. This study ...
... Virtual Radiologic (vRad), a technology-enabled national radiology ... Sales & Customer Service. vRad® Results (SM) is a ... that provides secure access to images and radiology reports ... devices and the Internet. vRad received the award in ...
Cached Medicine Technology:Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 2Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 3Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 4Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 5Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 6Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 7Reportlinker Adds Cardiac Marker Diagnostic Testing Markets 8Virtual Radiologic Wins Stevie® Award for Improving Patient Care through Mobile Technology 2
(Date:8/4/2015)... ... August 04, 2015 , ... ... brings an automatic end to driving, says the August 2015 Harvard Health Letter. ... okay to drive. It requires an individual assessment of skills," says Lissa Kapust, ...
(Date:8/4/2015)... NY (PRWEB) , ... August 04, 2015 , ... ... mortgage lender specializing in healthcare finance, announced the closing of a $118 million ... two campus health system located in Smithfield and Clayton, North Carolina. JHSC ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... Process Chemistry and Scale-up Online Seminar featuring researchers from Lubrizol, Pfizer, and ... at 1:00 PM EDT. , Process development project timelines often require informed decisions ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Updated enrollment ... (AIS) in-house research team, can now be accessed at http://www.AISHealth.com . The data ... Directory of Health Plans: 2015, the tables and charts on the website’s “Data” section ...
(Date:8/4/2015)... Ill. (PRWEB) , ... August 04, 2015 , ... ... and the specialty in which the physician is board-certified is increasingly influential in ... for Dermatologic Surgery. , The 2015 ASDS Consumer Survey on Cosmetic Dermatologic Procedures ...
Breaking Medicine News(10 mins):Health News:Assessment Can Help Older Drivers Keep Driving Safely, from the August 2015 Harvard Health Letter 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 4
... driving the trend, study says , , TUESDAY, Nov. 6 ... disease is on the rise, and diabetes and high blood ... the increase, a new study suggests. , "When we looked ... was more common than previously appreciated," said lead researcher Dr. ...
... ... http://www.amerathonclub.com Encourages Consistent Exercise for Individuals and ... Families -, PITTSBURGH, ... while maintaining a healthy,lifestyle. The Amerathon Club has introduced a new online and interactive,total ...
... Healthcare NHS Trust Implements Ericom,s Alternative to Citrix ... ... 6 ,Ericom(R) Software, a leading provider of Enterprise-Wide Application,Access solutions, ... selected PowerTerm(R) WebConnect Enterprise edition to provide,employees with secure access ...
... is available in Spanish . , ANN ARBOR, Mich. ... the fact that nearly one in five American women still smokes, ... possible reasons for the stubborn persistence of smoking, fear of weight ... University of Michigan Health System researcher who has devoted much of ...
... work together to maintain addiction, study suggests , , TUESDAY, ... know all too well, drinking and smoking tend to ... might be so. , It,s well known that, "The ... someone continues smoking," noted lead researcher Thomas J. Gould, ...
... for State,s Second Site, ATLANTA, Nov. 6 ... has named Atlanta Medical Center as Georgia,s second,hospital ... March,of Dimes NICU Family Support(R) provides information and ... newborns being cared for in,a Neonatal Intensive Care ...
Cached Medicine News:Health News:Kidney Disease Increasing in U.S. 2Health News:Kidney Disease Increasing in U.S. 3Health News:Innovative Amerathon Club Website 'Virtual' Journey to Good Health 2Health News:UK Government (NHS) Selects Ericom to Enable Secure Application Access for its Medical and Administrative Staff 2Health News:Is fear of gaining weight keeping many women from trying to quit smoking? 2Health News:Is fear of gaining weight keeping many women from trying to quit smoking? 3Health News:Is fear of gaining weight keeping many women from trying to quit smoking? 4Health News:Nicotine Plus Alcohol May Be Tough to Beat 2Health News:Nicotine Plus Alcohol May Be Tough to Beat 3Health News:Georgia Receives Second March of Dimes NICU Family Support(R) Project 2Health News:Georgia Receives Second March of Dimes NICU Family Support(R) Project 3
VersaStep™ Reposable Sterilization Trays....
... device is comprised of the following components. ... port are also packaged in the following ... with 12 mm Step™ cannula assembly and ... mm locking cone with 10/12 mm Reposable ...
... components are supplied sterile. , ,The Step™ ... sterile in 2/3, 5, 7/8, 10 and 12 ... They are used in conjunction with the Step™ ... Expandable Sleeve. The 5, 7/8, 10 and 12 ...
... VERSAPORT™ PLUS V2 RT single-use obturator has a ... , ,The Auto Suture™ VERSAPORT™ PLUS V2 ... 5-12, 11 mm and 12 mm diameters with ... and 5 mm short single-use obturators are not ...
Medicine Products: